JP2017006120A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017006120A5 JP2017006120A5 JP2016109398A JP2016109398A JP2017006120A5 JP 2017006120 A5 JP2017006120 A5 JP 2017006120A5 JP 2016109398 A JP2016109398 A JP 2016109398A JP 2016109398 A JP2016109398 A JP 2016109398A JP 2017006120 A5 JP2017006120 A5 JP 2017006120A5
- Authority
- JP
- Japan
- Prior art keywords
- hla
- molecule
- drb1
- cancer
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010225806 | 2010-10-05 | ||
| JP2010225806 | 2010-10-05 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012537718A Division JP6134139B2 (ja) | 2010-10-05 | 2011-10-04 | ヘルパーｔ細胞の活性化方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017237964A Division JP2018093870A (ja) | 2010-10-05 | 2017-12-12 | ヘルパーｔ細胞の活性化方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017006120A JP2017006120A (ja) | 2017-01-12 |
| JP2017006120A5 true JP2017006120A5 (enExample) | 2017-05-25 |
| JP6298101B2 JP6298101B2 (ja) | 2018-03-20 |
Family
ID=45927725
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012537718A Active JP6134139B2 (ja) | 2010-10-05 | 2011-10-04 | ヘルパーｔ細胞の活性化方法 |
| JP2016109398A Active JP6298101B2 (ja) | 2010-10-05 | 2016-05-31 | ヘルパーｔ細胞の活性化方法 |
| JP2017237964A Pending JP2018093870A (ja) | 2010-10-05 | 2017-12-12 | ヘルパーｔ細胞の活性化方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012537718A Active JP6134139B2 (ja) | 2010-10-05 | 2011-10-04 | ヘルパーｔ細胞の活性化方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017237964A Pending JP2018093870A (ja) | 2010-10-05 | 2017-12-12 | ヘルパーｔ細胞の活性化方法 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10654892B2 (enExample) |
| EP (1) | EP2626418B8 (enExample) |
| JP (3) | JP6134139B2 (enExample) |
| KR (3) | KR102171794B1 (enExample) |
| CN (2) | CN103298928B (enExample) |
| AR (1) | AR083295A1 (enExample) |
| AU (1) | AU2011313327B2 (enExample) |
| BR (1) | BR112013008230A2 (enExample) |
| CA (1) | CA2813557C (enExample) |
| CO (1) | CO6710946A2 (enExample) |
| EA (1) | EA037547B1 (enExample) |
| ES (1) | ES2849187T3 (enExample) |
| IL (2) | IL225536B (enExample) |
| MX (2) | MX361299B (enExample) |
| MY (1) | MY170306A (enExample) |
| NZ (2) | NZ609460A (enExample) |
| PH (1) | PH12013500654A1 (enExample) |
| SG (3) | SG10202108581TA (enExample) |
| TW (2) | TWI608099B (enExample) |
| WO (1) | WO2012046730A1 (enExample) |
| ZA (1) | ZA201303056B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080070835A1 (en) | 2003-11-05 | 2008-03-20 | International Institute Of Cancer Immunology, Inc | Hla-Dr-Binding Antigen Peptide Derived From Wt1 |
| CA2626238C (en) | 2005-10-17 | 2015-10-06 | Memorial Sloan Kettering Cancer Center | Wt1 hla class ii-binding peptides and compositions and methods comprising same |
| US9265816B2 (en) | 2006-04-10 | 2016-02-23 | Sloan Kettering Institute For Cancer Research | Immunogenic WT-1 peptides and methods of use thereof |
| PL2119778T3 (pl) | 2007-02-27 | 2016-04-29 | Int Inst Cancer Immunology Inc | Sposób aktywacji pomocniczej komórki T oraz kompozycja do zastosowania w tym sposobie |
| AR076349A1 (es) | 2009-04-23 | 2011-06-01 | Int Inst Cancer Immunology Inc | Peptido auxiliar del antigeno del cancer |
| NZ609460A (en) * | 2010-10-05 | 2015-07-31 | Otsuka Pharma Co Ltd | Method for activating helper t cell |
| CA2861206C (en) | 2012-01-13 | 2021-07-06 | Richard J. O'reilly | Immunogenic wt-1 peptides and methods of use thereof |
| CA2884366A1 (en) | 2012-09-12 | 2014-03-20 | International Institute Of Cancer Immunology, Inc. | Antigen-specific helper t-cell receptor genes |
| EA201591168A1 (ru) * | 2012-12-17 | 2016-05-31 | Оцука Фармасьютикал Ко., Лтд. | Способ активации хелперной t-клетки |
| US10815273B2 (en) | 2013-01-15 | 2020-10-27 | Memorial Sloan Kettering Cancer Center | Immunogenic WT-1 peptides and methods of use thereof |
| CN110078813B (zh) | 2013-01-15 | 2023-03-28 | 纪念斯隆凯特林癌症中心 | 免疫原性wt-1肽和其使用方法 |
| EP2982681B8 (en) | 2013-03-29 | 2018-11-07 | Sumitomo Dainippon Pharma Co., Ltd. | Wt1-antigen peptide conjugate vaccine |
| US10253075B2 (en) | 2014-02-26 | 2019-04-09 | tella, Inc. | WT1 antigenic polypeptide, and anti-tumor agent containing said polypeptide |
| JP6723164B2 (ja) | 2014-12-25 | 2020-07-15 | 株式会社癌免疫研究所 | Ｔ細胞集団の改変方法 |
| CN106565836B (zh) * | 2015-10-10 | 2020-08-18 | 中国科学院广州生物医药与健康研究院 | 高亲和力的可溶性pdl-1分子 |
| DK3539974T5 (en) | 2016-11-09 | 2024-05-27 | Univ Osaka | Method for modifying t cell population |
| US12383608B2 (en) | 2016-11-30 | 2025-08-12 | Sumitomo Pharma Co., Ltd. | WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides |
| JPWO2019131722A1 (ja) * | 2017-12-27 | 2021-01-14 | 大日本住友製薬株式会社 | Ｗｔ１由来ペプチドのコンジュゲート体およびこれを含む組成物 |
| KR102267463B1 (ko) * | 2018-02-15 | 2021-06-21 | 코쿠리츠다이가쿠호진 아사히카와 이카다이가쿠 | 암 항원 펩티드 |
| KR20210049119A (ko) * | 2018-08-22 | 2021-05-04 | 프레드 헛친슨 켄서 리서치 센터 | Kras 또는 her2 항원을 표적으로 하는 면역요법 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5726288A (en) | 1989-11-13 | 1998-03-10 | Massachusetts Institute Of Technology | Localization and characterization of the Wilms' tumor gene |
| HK1038929B (zh) | 1998-07-31 | 2005-05-06 | 株式会社国际癌症免疫研究所 | 基於癌抑制基因wt1的产物的癌抗原 |
| PL201881B1 (pl) | 1998-09-30 | 2009-05-29 | Corixa Corp | Izolowany polipeptyd składający się z immunogennej części natywnego WT1, zawierająca go kompozycja farmaceutyczna i szczepionka oraz polinukleotyd kodujący ten polipeptyd |
| US7063854B1 (en) | 1998-09-30 | 2006-06-20 | Corixa Corporation | Composition and methods for WTI specific immunotherapy |
| US20030235557A1 (en) | 1998-09-30 | 2003-12-25 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| CA2401070A1 (en) | 2000-02-22 | 2001-08-30 | Corixa Corporation | Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| EP1371664B1 (en) | 2001-03-22 | 2008-01-09 | International Institute of Cancer Immunology, Inc. | Wti modified peptide |
| GB0108491D0 (en) | 2001-04-04 | 2001-05-23 | Gendaq Ltd | Engineering zinc fingers |
| DE60238958D1 (de) | 2001-06-29 | 2011-02-24 | Chugai Pharmaceutical Co Ltd | Krebsimpfstoff mit einem Krebs-Antigen auf Grundlage des Produkts aus dem Tumorunterdrückungsgen WT1 und einem kationischen Liposom |
| US8735357B2 (en) | 2001-09-28 | 2014-05-27 | International Institute Of Cancer Immunology, Inc. | Method of inducing antigen-specific T cells |
| US20050002951A1 (en) | 2001-09-28 | 2005-01-06 | Haruo Sugiyama | Novel method of inducing antigen-specific t cells |
| WO2003106682A1 (ja) | 2002-06-12 | 2003-12-24 | 中外製薬株式会社 | Ｈｌａ−ａ２４拘束性癌抗原ペプチド |
| AU2003262094A1 (en) | 2002-09-12 | 2004-04-30 | Haruo Sugiyama | Cancer antigen peptide preparation |
| EP1548028B1 (en) | 2002-09-20 | 2009-09-09 | International Institute of Cancer Immunology, Inc. | Substituted type peptides of wt1 |
| KR101399678B1 (ko) | 2003-01-15 | 2014-05-27 | 추가이 세이야쿠 가부시키가이샤 | 이량체화 펩티드 |
| CA2530184C (en) | 2003-06-27 | 2015-10-06 | Haruo Sugiyama | Method of selecting patients suitable for wt1 vaccine |
| US20080070835A1 (en) | 2003-11-05 | 2008-03-20 | International Institute Of Cancer Immunology, Inc | Hla-Dr-Binding Antigen Peptide Derived From Wt1 |
| JP4886507B2 (ja) | 2004-03-31 | 2012-02-29 | 株式会社癌免疫研究所 | Ｗｔ１由来の癌抗原ペプチド |
| US7608769B2 (en) * | 2004-05-12 | 2009-10-27 | First Act, Inc. | Packaged drum set |
| JP4719876B2 (ja) | 2005-04-04 | 2011-07-06 | 国立大学法人愛媛大学 | Ｈｌａクラスｉｉ拘束性ｗｔ１抗原ペプチド |
| CA2626238C (en) | 2005-10-17 | 2015-10-06 | Memorial Sloan Kettering Cancer Center | Wt1 hla class ii-binding peptides and compositions and methods comprising same |
| ES2352855T3 (es) | 2005-11-30 | 2011-02-23 | International Institute Of Cancer Immunology, Inc. | Nuevos compuestos peptídicos del tumor de wilms. |
| US7420880B2 (en) | 2005-12-29 | 2008-09-02 | Timex Group B.V. | Multimode electronic device with calibrating/setting mechanism |
| CN102250211A (zh) | 2006-02-22 | 2011-11-23 | 株式会社癌免疫研究所 | Hla-a*3303限制性wt1肽和包含此肽的药物组合物 |
| US9265816B2 (en) | 2006-04-10 | 2016-02-23 | Sloan Kettering Institute For Cancer Research | Immunogenic WT-1 peptides and methods of use thereof |
| CA2886621A1 (en) | 2006-12-28 | 2008-07-10 | International Institute Of Cancer Immunology, Inc. | Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| PL2119778T3 (pl) * | 2007-02-27 | 2016-04-29 | Int Inst Cancer Immunology Inc | Sposób aktywacji pomocniczej komórki T oraz kompozycja do zastosowania w tym sposobie |
| US10093977B2 (en) | 2007-03-05 | 2018-10-09 | International Institute Of Cancer Immunology, Inc. | Cancer antigen-specific T-cell receptor gene, peptide encoded by the gene, and use of them |
| AR076349A1 (es) | 2009-04-23 | 2011-06-01 | Int Inst Cancer Immunology Inc | Peptido auxiliar del antigeno del cancer |
| NZ609460A (en) * | 2010-10-05 | 2015-07-31 | Otsuka Pharma Co Ltd | Method for activating helper t cell |
| EA201591168A1 (ru) | 2012-12-17 | 2016-05-31 | Оцука Фармасьютикал Ко., Лтд. | Способ активации хелперной t-клетки |
-
2011
- 2011-10-04 NZ NZ609460A patent/NZ609460A/en unknown
- 2011-10-04 CA CA2813557A patent/CA2813557C/en active Active
- 2011-10-04 SG SG10202108581TA patent/SG10202108581TA/en unknown
- 2011-10-04 MX MX2013003884A patent/MX361299B/es active IP Right Grant
- 2011-10-04 TW TW100135857A patent/TWI608099B/zh active
- 2011-10-04 KR KR1020207004213A patent/KR102171794B1/ko active Active
- 2011-10-04 EP EP11830662.0A patent/EP2626418B8/en active Active
- 2011-10-04 KR KR1020137011554A patent/KR20140009168A/ko not_active Ceased
- 2011-10-04 WO PCT/JP2011/072874 patent/WO2012046730A1/ja not_active Ceased
- 2011-10-04 CN CN201180058552.2A patent/CN103298928B/zh active Active
- 2011-10-04 AR ARP110103676A patent/AR083295A1/es unknown
- 2011-10-04 KR KR1020197008457A patent/KR102079480B1/ko not_active Expired - Fee Related
- 2011-10-04 SG SG2013025622A patent/SG189287A1/en unknown
- 2011-10-04 TW TW105107752A patent/TW201623616A/zh unknown
- 2011-10-04 CN CN201610191489.4A patent/CN105802910A/zh active Pending
- 2011-10-04 EA EA201390509A patent/EA037547B1/ru unknown
- 2011-10-04 NZ NZ703560A patent/NZ703560A/en unknown
- 2011-10-04 BR BR112013008230A patent/BR112013008230A2/pt not_active Application Discontinuation
- 2011-10-04 JP JP2012537718A patent/JP6134139B2/ja active Active
- 2011-10-04 US US13/877,768 patent/US10654892B2/en active Active
- 2011-10-04 AU AU2011313327A patent/AU2011313327B2/en not_active Ceased
- 2011-10-04 MY MYPI2013001197A patent/MY170306A/en unknown
- 2011-10-04 SG SG10201508252PA patent/SG10201508252PA/en unknown
- 2011-10-04 PH PH1/2013/500654A patent/PH12013500654A1/en unknown
- 2011-10-04 ES ES11830662T patent/ES2849187T3/es active Active
-
2013
- 2013-04-02 IL IL225536A patent/IL225536B/en not_active IP Right Cessation
- 2013-04-05 MX MX2018008436A patent/MX2018008436A/es unknown
- 2013-04-25 ZA ZA2013/03056A patent/ZA201303056B/en unknown
- 2013-05-03 CO CO13111246A patent/CO6710946A2/es unknown
-
2016
- 2016-05-03 IL IL245440A patent/IL245440A0/en unknown
- 2016-05-31 JP JP2016109398A patent/JP6298101B2/ja active Active
-
2017
- 2017-12-12 JP JP2017237964A patent/JP2018093870A/ja active Pending
-
2020
- 2020-03-31 US US16/835,761 patent/US12415833B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017528117A5 (enExample) | ||
| HRP20241268T1 (hr) | Trispecifični proteini i postupci primjene | |
| JP2019522461A5 (enExample) | ||
| JP2019508013A5 (enExample) | ||
| JP2017537611A5 (enExample) | ||
| JP2018534950A5 (enExample) | ||
| EA201590986A1 (ru) | Антитела к ceacam5 и их применения | |
| JP2015522576A5 (enExample) | ||
| JP2019501141A5 (enExample) | ||
| JP2015134796A5 (enExample) | ||
| JP2017501129A5 (enExample) | ||
| JPWO2019107530A5 (enExample) | ||
| JP2016538344A5 (enExample) | ||
| IL308807B2 (en) | Combination therapy for treating cancer | |
| EP3533877A3 (de) | Viraler vektor für den zielgerichteten gentransfer in gehirn und rückenmark | |
| JP2014051497A5 (enExample) | ||
| JP2012521768A5 (enExample) | ||
| JP2016531927A5 (enExample) | ||
| JPWO2019156137A5 (enExample) | ||
| JP2015520178A5 (enExample) | ||
| CY1117872T1 (el) | Ολιγοπεπτιδικες ενωσεις και χρησεις εξ' aυτων | |
| JP2012115277A5 (enExample) | ||
| JP2012529293A5 (enExample) | ||
| JP2019534884A5 (enExample) | ||
| MX353813B (es) | Moleculas de union a vegf. |